If you could vote on Brexit now which option would you choose?
   

India's Covaxin 77.8% Effective Against Covid in Lancet Study


Covaxin, a vaccine developed by India’s government medical research agency and Bharat Biotech International Ltd., was found to have a 77.8% efficacy rate against symptomatic Covid-19 in a long-awaited analysis published in The Lancet. Covaxin, which uses traditional, inactivated-virus technology, “induces a robust antibody response” two weeks after two doses are given, The Lancet said in a statement. No severe-vaccine-related deaths or adverse events were recorded during a randomized trial involving 24,419 participants aged 18-97 years between Nov. 2020 and May 2021 in India, the medical journal said.

Bloomberg - November 11, 2021

View the full story here: https://www.bloomberg.com/news/articles/2021-11-11/india-s-covaxin-77-8-effective-against-covid-in-lancet-study